PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models

Cancer immunotherapy has revolutionized the way different neoplasms are treated. Among the different variations of cancer immunotherapy, the checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis have been validated and are currently used in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Daehyun, Lee, Seung Soo, Moon, Hyungwon, Park, So Yeon, Lee, Hak Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822446/
https://www.ncbi.nlm.nih.gov/pubmed/33374574
http://dx.doi.org/10.3390/ph14010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822446/
https://www.ncbi.nlm.nih.gov/pubmed/33374574
http://dx.doi.org/10.3390/ph14010006

Ejemplares similares